bioAffinity Technologies receives Canadian patent for lung cancer test

Go back to bioAffinity Technologies receives Canadian patent for lung cancer test
(NASDAQ: BIAF) Delayed: 0.83 -0.01 (1.19%)
Previous Close $0.84    52 Week High
Open $0.84    52 Week Low
Day High $0.87    P/E N/A 
Day Low $0.83    EPS
Volume 141,997       

(NASDAQ: BIAFW) Delayed: 0.13 --0 (-0%)
Previous Close $0.13    52 Week High
Open $0.13    52 Week Low
Day High $0.13    P/E N/A 
Day Low $0.13    EPS
Volume 1,973